Omicron, the less active vaccinated antibodies against the variant
The anti-Covid vaccines could lose part of their effectiveness in the face of the Omicron variant: this is suggested by five papers just published in
The anti-Covid vaccines could lose part of their effectiveness in the face of the Omicron variant: this is suggested by five papers just published in
(ANSA) – ROME, 02 DEC – The Moderna and Pfizer-BioNTech vaccines both have a very high efficacy, but the former offers a slightly higher protection.
The risk of contagion for those vaccinated with Pfizer-BioNTech begins to increase 90 days after the second dose: this is demonstrated by a study on
(ANSAmed) – BELGRADE, NOVEMBER 07 – Serbian President Aleksandar Vucic received the third dose of anticovid vaccine today. At the vaccination center of the Belgrade